NEGRO, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 3.887
EU - Europa 1.127
AS - Asia 708
AF - Africa 42
SA - Sud America 24
OC - Oceania 4
Totale 5.792
Nazione #
US - Stati Uniti d'America 3.851
IT - Italia 502
SG - Singapore 272
IN - India 227
SE - Svezia 161
CN - Cina 139
FI - Finlandia 88
IE - Irlanda 80
DE - Germania 65
BG - Bulgaria 61
ID - Indonesia 44
UA - Ucraina 44
TG - Togo 38
GB - Regno Unito 37
CA - Canada 33
RU - Federazione Russa 31
AR - Argentina 17
NL - Olanda 14
FR - Francia 12
BE - Belgio 8
RO - Romania 8
TR - Turchia 7
JP - Giappone 6
CH - Svizzera 5
CL - Cile 5
HK - Hong Kong 4
AU - Australia 3
ES - Italia 3
KG - Kirghizistan 3
MX - Messico 3
PL - Polonia 3
DZ - Algeria 2
LT - Lituania 2
AZ - Azerbaigian 1
BR - Brasile 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
IL - Israele 1
KR - Corea 1
KZ - Kazakistan 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
SA - Arabia Saudita 1
SC - Seychelles 1
Totale 5.792
Città #
Fairfield 687
Chandler 324
Ashburn 282
Woodbridge 266
Seattle 248
Cambridge 216
Houston 210
Wilmington 201
Singapore 194
Ann Arbor 135
Rome 130
Princeton 120
San Paolo di Civitate 94
Plano 89
Beijing 79
Lawrence 78
Dublin 72
Sofia 61
San Diego 58
Boston 57
Millbury 54
Santa Clara 51
Norwalk 47
Jakarta 44
Lomé 38
Phoenix 34
Milan 32
Bremen 31
Dearborn 30
New York 27
Helsinki 22
Toronto 21
Des Moines 20
Moscow 20
Federal 17
Andover 13
Torino 13
Bühl 12
Jacksonville 12
Southend 12
San Mateo 10
Turin 10
Nanjing 9
Brussels 8
London 8
Falls Church 7
Frankfurt am Main 7
Fremont 7
Kunming 7
Istanbul 6
Naples 6
Falkenstein 5
Los Angeles 5
Amsterdam 4
Boardman 4
Catania 4
Dallas 4
Florence 4
Guangzhou 4
Hefei 4
Hong Kong 4
Jinan 4
Montréal 4
Ottawa 4
Redwood City 4
Bishkek 3
Hangzhou 3
Kumamoto 3
Mannheim 3
Nagercoil 3
Padova 3
Pordenone 3
Pratovecchio 3
Redmond 3
Tokyo 3
Torri di Quartesolo 3
Altamura 2
Bengaluru 2
Brentford 2
Brescia 2
Buccinasco 2
Capena 2
Casalnuovo di Napoli 2
Cassano delle Murge 2
Delhi 2
Edmonton 2
Enschede 2
Falakata 2
Garden City 2
Jesi 2
Kozhikode 2
Labico 2
Lviv 2
L’Aquila 2
Mendicino 2
Mestre 2
Oristano 2
Palermo 2
Paris 2
Royal Leamington Spa 2
Totale 4.375
Nome #
Ascessi cerebrali multipli da Streptococcus constellatus 283
Altered serum levels of kynurenine metabolites in patients affected by cluster headache 111
Development and validation of the ID-EC - The ITALIAN version of the identify chronic migraine 100
Pharmacokinetic evaluation of zolmitriptan for the treatment of migraines 99
Altered kynurenine pathway metabolites in serum of chronic migraine patients 98
Choosing the safest acute therapy during chronic migraine prophylactic treatment. pharmacokinetic and pharmacodynamic considerations 93
Gene variants with suicidal risk in a sample of subjects with chronic migraine and affective temperamental dysregulation 88
Nonthyroidal illness syndrome (NTIS) in severe COVID-19 patients: role of T3 on the Na/K pump gene expression and on hydroelectrolytic equilibrium 88
Changing the approach to anticoagulant therapy in older patients with multimorbidity using a precision medicine approach 87
Acute, transitional and long-term cluster headache treatment. pharmacokinetic issues 86
Lack of association between oxidative stress-related gene polymorphisms and chronic migraine in an Italian population 85
Eletriptan in the management of acute migraine. An update on the evidence for efficacy, safety, and consistent response 83
Attivazione del sistema prorenina/renina nella nefropatia diabetica sperimentale 81
Abnormal synaptic Ca(2+) homeostasis and morphology in cortical neurons of familial hemiplegic migraine type 1 mutant mice 80
OnabotulinumtoxinA 155 U in medication overuse headache. a two years prospective study 80
Emerging treatment for chronic migraine and refractory chronic migraine 79
Pharmacokinetic evaluation of frovatriptan 76
White matter hyperintensities and self-reported depression in a sample of patients with chronic headache 76
Treatment of Perimenstrual Migraine with Triptans. an Update 76
A two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache. a real-world experience 76
Lasmiditan for the treatment of migraine 76
Anti-CGRP monoclonal antibodies in migraine. current perspectives 75
Migraine and cluster headache show impaired neurosteroids patterns 74
O066. Kynurenine pathway metabolites in cluster headache 73
Ictal epileptic headache. an old story with courses and appeals 73
Pharmacokinetic evaluation of almotriptan for the treatment of migraines 72
Framing comorbidities and co-occurrences in a migraine with aura patient 71
A PRISMA-compliant systematic review of the endpoints employed to evaluate symptomatic treatments for primary headaches 71
A six year retrospective review of occipital nerve stimulation practice--controversies and challenges of an emerging technique for treating refractory headache syndromes 70
A critical evaluation on MOH current treatments 70
Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine. A post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial 69
CGRP receptor antagonists. an expanding drug class for acute migraine? 69
Serotonin receptor agonists in the acute treatment of migraine. a review on their therapeutic potential 68
Pharmacokinetics and pharmacodynamics of new acute treatments for migraine 68
Multi-omic approach identifies a transcriptional network coupling innate immune response to proliferation in the blood of COVID-19 cancer patients 68
Burden and attitude to resistant and refractory migraine. a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance 67
A 2-year prospective evaluation study on onabotulinumtoxinA 155 U in chronic migraine 64
Pharmacokinetics and safety of a new aspirin formulation for the acute treatment of primary headaches 63
Spreading depression and the clinical correlates of migraine 63
Treatment of menstrual migraine. utility of control of related mood disturbances 62
Chronic migraine plus medication overuse headache. two entities or not? 62
Chronic migraine. comorbidities, risk factors, and rehabilitation 61
Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine. additional findings from the randomized, sham-controlled, double-blind PRESTO trial 61
Sumatriptan succinate. pharmacokinetics of different formulations in clinical practice 60
Refractory chronic cluster headache. a consensus statement on clinical definition from the European Headache Federation 60
Long-term treatment benefits and prolonged efficacy of OnabotulinumtoxinA in patients affected by chronic migraine and medication overuse headache over 3 years of therapy 60
Job satisfaction mediates the association between perceived disability and work productivity in migraine headache patients 60
Chronic migraine treatment. from OnabotulinumtoxinA onwards 60
Headache service quality. evaluation of quality indicators in 14 specialist-care centres 59
Impact of migraine on fibromyalgia symptoms 59
Refractory chronic migraine. a consensus statement on clinical definition from the European Headache Federation 59
A case of late onset hypogammaglobulinemia: multiple myeloma or common variable immunodeficiency? 58
Once-monthly galcanezumab for the prevention of migraine in adults. an evidence-based descriptive review and potential place in therapy 57
Coronavirus disease 2019 in patients with cardiovascular disease. clinical features and implications on cardiac biomarkers assessment 57
Rare primary headaches in Italian tertiary Headache Centres. Three year nationwide retrospective data from the RegistRare Network 56
Gepants for the treatment of migraine 56
Rapid referral for headache management from emergency department to headache centre. four years data 56
Sodium channel antagonists for the treatment of migraine 55
Quality indicators in headache care. an implementation study in six Italian specialist-care centres 55
Headache and pregnancy. a systematic review 54
Cost of chronic and episodic migraine patients in continuous treatment for two years in a tertiary level headache Centre 54
New insights into the cardiovascular risk of migraine and the role of white matter hyperintensities. is gold all that glitters? 53
Acute sleep deprivation enhances susceptibility to the migraine substrate cortical spreading depolarization 53
Male and female sex hormones in primary headaches 52
MACROPHAGES BULLYING T CELLS IN TYPE-A STANFORD ACUTE AORTIC DISSECTION 51
General principles of pharmacotherapy for headache disorders 50
Patient selection for migraine preventive treatment with anti-CGRP(r) monoclonal antibodies 50
Overattachment and perceived disability in chronic migraineurs 49
MACROPHAGIC VERSATILE OUTCOME IN CRITICAL CAROTID STENOSIS AND ACUTE AORTIC DISSECTION 48
A 2 years prospective evaluation study on onabotulinumtoxinA 195 U in chronic migraine 48
Direct and indirect costs of cluster headache. a prospective analysis in a tertiary level headache centre 48
Evaluating and managing severe headache in the emergency department 46
Chronic migraine complicated by medication overuse headache 45
Medical Interventions for Migraine That Has Become Difficult to Treat 45
Eptinezumab for the treatment of migraine 45
Drug-resistant chronic cluster headache successfully treated with supraorbital plus occipital nerve stimulation. A rare case report 43
.Ipercalcemia-LES: un'associazione rara? 42
The plasma fibrinogen as a marker of subclinical carotid atherosclerosis 40
Abdominal aortic aneurysm following acute pancreatitis 39
The wide spectrum of the granulomatous diseases 38
Is There a Gender Difference in the Response to onabotulinumtoxinA in Chronic Migraine? Insights from a Real-Life European Multicenter Study on 2879 Patients 37
Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine. Insights from a Real-Life European Multicenter Study 37
A rare opportunistic infectious disease 35
Un caso di miocardio non compattato isolato nell’adulto 34
Headache and Cardiovascular Disease 33
Lymphocyte subpopulations in acute aortic dissection 33
Horton’s arteritis and solitari extra-medullary plasmacytoma: first description of a case. 32
Un caso di polmonite 32
Vasculiti isolate del sistema nervoso centrale. 109° Congresso Nazionale SIMI. 32
Nummular headache. a gender-oriented perspective on a case series from the RegistRare Network 32
The role of physical activity in the prevention and treatment of chronic diseases 30
Sensitivity to acute cerebral ischemic injury in migraineurs. A retrospective case-control study 30
Noninvasive vagus nerve stimulation as acute therapy for migraine. The randomized PRESTO study 30
What is changing in chronic migraine treatment? An algorithm for onabotulinumtoxinA treatment by the Italian chronic migraine group 30
Low-titre anti-phospholipid antibodies and recurrent pregnancy losses 29
CID e Chron: un’associazione occasionale? 28
Espressione e localizzazione di galectina-3 in placche carotidee umane: possibile ruolo nel processo osteogenico aterosclerotico. 28
How to measure headache service quality. evaluation of quality indicators in 14 european specialist-care centres 28
Abnormal synaptic morphology and neuronal Ca2+-homeostasis in migraine mutant mice 28
Il gel piastrinico nel trattamento del “piede diabetico”: esperienza preliminare 27
Totale 6.040
Categoria #
all - tutte 17.705
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.705


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020823 0 0 0 0 0 153 157 156 145 89 87 36
2020/2021426 59 42 45 38 11 15 14 26 72 58 34 12
2021/20221.143 11 90 95 26 164 64 43 96 83 67 187 217
2022/20231.135 206 292 62 142 108 113 19 50 99 15 25 4
2023/2024552 37 72 26 55 28 99 5 41 8 68 59 54
2024/2025402 34 45 60 100 69 94 0 0 0 0 0 0
Totale 6.277